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A comparison of a central London latent TB screening algorithm with national UK and US 
algorithms and the effect on LTBI diagnosis 
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Introduction  
There is continuing debate over the most effective strategy for the use of interferon gamma release 
assays (IGRAs) in clinical practice and this is reflected in the diversity of published recommendations. 
Practice in UK TB contact screening clinics reflects these widely divergent views.  
The aims of our study were to: 
1. Enumerate the prevalence of latent TB infection (LTBI) according to US, UK and local 
screening protocols  
2. Explore which algorithm is the most effective in a central London TB clinic  
 
Methods 
This was a cross sectional retrospective study comprising 558 consecutive adult contacts of TB cases 
that attended for screening tests for LTBI 2008-2010. The screening results were applied to patient 
management algorithms derived from US guidance (IGRA or tuberculin skin test but not both), UK 
NICE guidance (two step approach), and our local service (concurrent IGRA and TST). For the purpose 
of this analysis, LTBI was defined as the outcome predetermined by each algorithm. 
 
Results 
In our cohort, NICE guidance had the highest completion rate (97%) with the most complex algorithm 
(local practice) at 87%. The diagnosis of LTBI had a variability of 5-26% dependent on which algorithm 
was used. NICE screens contacts aged >35 years with a chest x-ray and misses the immunodiagnosis 
of LTBI in 12-16% of this group. The NICE approach is also less sensitive in contacts aged <35 years 
because of the two step approach (IGRA is only performed following a positive TST) and the failure to 
rescreen contacts of pulmonary cases who are TST or IGRA negative at the initial screen. 11 (4.6%) of 
pulmonary TB contacts aged <35 years that would be discharged by NICE had a TST or IGRA 
conversion. The US IGRA alone algorithm misses a proportion (6.9%) of individuals; 11 (2%) had a 
strongly positive TST (> 20mm), and of these, 5 had a TST conversion varying 6-16mm. This approach 
also potentially over diagnosed 8 (2%) of contacts who reverted on rescreen when initially discordant 
(TST negative / IGRA positive). 
 
Conclusion 
The sensitivity of the screening depends not only on the performance of the tests but also what 
algorithm is used. As demonstrated in our local data, the overall effectiveness of any approach is also 
affected by how these impact on the patient journey and their ability to complete the screening 
process. These findings also highlight the impact of conversion and reversion phenomena in a clinical 
service.  
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